When doctors encounter a patient with a massive pulmonary embolism, they face a difficult choice: Is it wise to administer a drug that could save the patient's life, even though many people suffer life-threatening bleeding as a result?Based on new findings published in the American Journal of Medicine, Michigan State University researchers are answering that question in no uncertain terms.
Fuente : http://www.eurekalert.org/pub_releases/2013-02/msu...
Fuente : http://www.eurekalert.org/pub_releases/2013-02/msu...